Skip to main content

Advertisement

Log in

Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ozaki S, Harada T, Fujii S, Nakamura S, Miki H, Nakano A, et al. Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma. Int J Hematol. 2011;93:257–9.

    Article  PubMed  Google Scholar 

  2. Richardson PG, Schlossman RL, Weller E, Hideshima T, Mitsiades C, Davies F, et al. Immunomodulatory drug CC5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood. 2002;100:3063–7.

    Article  PubMed  CAS  Google Scholar 

  3. Zangari M, Elice F, Tricot G. Immunomodulatory drugs in multiple myeloma. Expert Opin Investig Drugs. 2005;14:1411–8.

    Article  PubMed  CAS  Google Scholar 

  4. Quach H, Ritchie D, Stewart AK, Neason P, Harrison S, Smyth MJ, et al. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia. 2010;24:22–32.

    Article  PubMed  CAS  Google Scholar 

  5. Dredge K, Marriott JB, Macdonald CD. Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer. 2002;87:1166–72.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

Drs. Matsumura I and Morita Y received a grant for research from Celgene Corporation. All other authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuyoshi Morita.

About this article

Cite this article

Morita, Y., Shimada, T., Yamaguchi, T. et al. Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide. Int J Hematol 94, 583–584 (2011). https://doi.org/10.1007/s12185-011-0973-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0973-x

Keywords

Navigation